Team:LIKA-CESAR-Brasil/Partnerships
From 2014.igem.org
Villaverde (Talk | contribs) |
|||
(9 intermediate revisions not shown) | |||
Line 12: | Line 12: | ||
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.2.0/css/bootstrap.min.css"> | <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.2.0/css/bootstrap.min.css"> | ||
- | < | + | <style type="text/css"> |
+ | body { | ||
+ | font-size:12px; | ||
+ | color:#111; | ||
+ | height:100%; | ||
+ | background:#ededed; | ||
+ | /*min-width: 1326px;*/ | ||
+ | } | ||
+ | .container { | ||
+ | width:80%; | ||
+ | background: rgb(255,255,255); /* Old browsers */ | ||
+ | background: -moz-linear-gradient(top, rgba(255,255,255,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */ | ||
+ | background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(255,255,255,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */ | ||
+ | background: -webkit-linear-gradient(top, rgba(255,255,255,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */ | ||
+ | background: -o-linear-gradient(top, rgba(255,255,255,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */ | ||
+ | background: -ms-linear-gradient(top, rgba(255,255,255,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */ | ||
+ | background: linear-gradient(to bottom, rgba(255,255,255,1) 0%,rgba(237,237,237,1) 100%); /* W3C */ | ||
+ | filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ffffff', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */ | ||
+ | } | ||
+ | .navbar-brand { | ||
+ | padding: 5px; | ||
+ | } | ||
+ | .col-md-10 { | ||
+ | width:100%; | ||
+ | padding: 20px 70px 20px 50px; | ||
+ | min-height:200px; | ||
+ | padding-bottom:50px; | ||
+ | } | ||
+ | .col-md-4 { | ||
+ | padding-bottom:70px; | ||
+ | } | ||
+ | .navbar-inverse { | ||
+ | background-color: #ededed; | ||
+ | border-color: #ededed; | ||
+ | } | ||
+ | .navbar-inverse .navbar-nav > .active > a, .navbar-inverse .navbar-nav > .active > a:hover, .navbar-inverse .navbar-nav > .active > a:focus { | ||
+ | color: #006600; | ||
+ | background-color: #8cff00; | ||
+ | } | ||
+ | .navbar-inverse .navbar-nav > .open > a, .navbar-inverse .navbar-nav > .open > a:hover, .navbar-inverse .navbar-nav > .open > a:focus { | ||
+ | color: #006600; | ||
+ | background-color: #8cff00; | ||
+ | } | ||
+ | .navbar-inverse .navbar-nav > li > a:hover, .navbar-inverse .navbar-nav > li > a:focus { | ||
+ | color: #006600; | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | .navbar-inverse .navbar-nav > li > a:focus { | ||
+ | color: #006600; | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | .nav > li > a { | ||
+ | display: block; | ||
+ | padding: 25px 15px; | ||
+ | position: relative; | ||
+ | } | ||
+ | .menu{ | ||
+ | color:black; | ||
+ | z-index:999; | ||
+ | position:relative; | ||
+ | float:right; | ||
+ | margin:auto; | ||
+ | } | ||
+ | .videohome{ | ||
+ | background:#ededed; | ||
+ | } | ||
+ | .menu ul{ | ||
+ | margin:0 auto; | ||
+ | } | ||
+ | .jumbotron { | ||
+ | background:url("https://static.igem.org/mediawiki/2014/7/7a/Banner_top.jpg"); | ||
+ | border-top: solid 5px #8cff00; | ||
+ | border-bottom: solid 5px #8cff00; | ||
+ | background-size:cover; | ||
+ | width:80%; | ||
+ | height:331px; | ||
+ | margin:auto; | ||
+ | margin-top:40px; | ||
+ | } | ||
+ | .jumbotron02 { | ||
+ | background:url("https://static.igem.org/mediawiki/2014/5/52/Banner_top02.jpg"); | ||
+ | border-top: solid 5px #8cff00; | ||
+ | border-bottom: solid 5px #8cff00; | ||
+ | background-size:cover; | ||
+ | width:80%; | ||
+ | height:331px; | ||
+ | margin:auto; | ||
+ | margin-top:80px; | ||
+ | } | ||
+ | .jumbotronSafety { | ||
+ | background:url("https://static.igem.org/mediawiki/2014/7/7a/Banner_top.jpg"); | ||
+ | border-top: solid 5px #8cff00; | ||
+ | border-bottom: solid 5px #8cff00; | ||
+ | background-size:cover; | ||
+ | width:80%; | ||
+ | height:331px; | ||
+ | margin:auto; | ||
+ | margin-top:80px; | ||
+ | } | ||
+ | .jumbotronParts { | ||
+ | background:url("https://static.igem.org/mediawiki/2014/b/be/Banner_top04.jpg"); | ||
+ | border-top: solid 5px #8cff00; | ||
+ | border-bottom: solid 5px #8cff00; | ||
+ | background-size:cover; | ||
+ | width:80%; | ||
+ | height:331px; | ||
+ | margin:auto; | ||
+ | margin-top:80px; | ||
+ | } | ||
+ | .jumbotronHuman { | ||
+ | background:url("https://static.igem.org/mediawiki/2014/1/12/Banner_top05.jpg"); | ||
+ | border-top: solid 5px #8cff00; | ||
+ | border-bottom: solid 5px #8cff00; | ||
+ | background-size:cover; | ||
+ | width:80%; | ||
+ | height:331px; | ||
+ | margin:auto; | ||
+ | margin-top:80px; | ||
+ | } | ||
+ | .jumbotronProject { | ||
+ | background:url("https://static.igem.org/mediawiki/2014/b/be/Banner_top04.jpg"); | ||
+ | border-top: solid 5px #8cff00; | ||
+ | border-bottom: solid 5px #8cff00; | ||
+ | background-size:cover; | ||
+ | width:80%; | ||
+ | height:331px; | ||
+ | margin:auto; | ||
+ | margin-top:80px; | ||
+ | } | ||
+ | .jumbotronAdvisors { | ||
+ | background:url("https://static.igem.org/mediawiki/2014/3/3b/Banner_top03.jpg"); | ||
+ | border-top: solid 5px #8cff00; | ||
+ | border-bottom: solid 5px #8cff00; | ||
+ | background-size:cover; | ||
+ | width:80%; | ||
+ | height:331px; | ||
+ | margin:auto; | ||
+ | margin-top:80px; | ||
+ | } | ||
+ | |||
+ | .igem-logo{ | ||
+ | background:url("https://static.igem.org/mediawiki/2014/4/4e/Banner_top_03.png") ; | ||
+ | background-color:transparent; | ||
+ | width: 50px; | ||
+ | height:50px; | ||
+ | z-index: 99; | ||
+ | background-repeat: no-repeat; | ||
+ | } | ||
+ | |||
+ | /* | ||
+ | .navbar .container { | ||
+ | min-width: 1322px; | ||
+ | z-index: 9999; | ||
+ | } | ||
+ | */ | ||
+ | |||
+ | h2 { | ||
+ | font-size: 26px; | ||
+ | color:#339900; | ||
+ | } | ||
+ | .videocapa{ | ||
+ | width:35%; | ||
+ | float:right; | ||
+ | min-height:300px; | ||
+ | margin-top:10px; | ||
+ | } | ||
+ | p { | ||
+ | font-size: 12px; | ||
+ | color:#444; | ||
+ | } | ||
+ | footer { | ||
+ | background:#b8b8b8; | ||
+ | width:100%; | ||
+ | padding: 50px; | ||
+ | clear:both; | ||
+ | position: relative; | ||
+ | bottom:0; | ||
+ | border-top: solid 8px #8cff00; | ||
+ | } | ||
+ | footer p { | ||
+ | margin:auto; | ||
+ | padding-top:10px; | ||
+ | text-align:center; | ||
+ | width:50%; | ||
+ | color:#006600; | ||
+ | } | ||
+ | .firstHeading { | ||
+ | display:none; | ||
+ | } | ||
+ | table{ | ||
+ | color:#888; | ||
+ | font-size:16px; | ||
+ | border: solid 1px #ccc; | ||
+ | } | ||
+ | h1 { | ||
+ | font-size: 26px; | ||
+ | color:#339900; | ||
+ | } | ||
+ | h2 { | ||
+ | font-size: 22px; | ||
+ | color:#339900; | ||
+ | } | ||
+ | h3 { | ||
+ | font-size: 18px; | ||
+ | color:#339900; | ||
+ | } | ||
+ | h4 { | ||
+ | font-size: 16px; | ||
+ | color:#339900; | ||
+ | } | ||
+ | |||
+ | .listHorizontal{ | ||
+ | list-style: none; | ||
+ | display:inline-block; | ||
+ | margin-left: 0.3em; | ||
+ | } | ||
+ | |||
+ | .listHorizontal li{ | ||
+ | padding: 0px 5px 0px 5px; | ||
+ | } | ||
+ | |||
+ | div#globalWrapper { | ||
+ | position: relative; | ||
+ | font-size: 100%; | ||
+ | width: 100%; | ||
+ | margin: 0; | ||
+ | padding: 0; | ||
+ | padding-bottom: 10px; | ||
+ | } | ||
+ | |||
+ | </style> | ||
</head> | </head> | ||
Line 30: | Line 260: | ||
<span class="icon-bar"></span> | <span class="icon-bar"></span> | ||
</button> | </button> | ||
- | <a class="navbar-brand" href=" | + | <a class="navbar-brand" href="https://2014.igem.org/Team:LIKA-CESAR-Brasil"><img src="https://static.igem.org/mediawiki/2014/5/55/Marca.png" alt="Marca LIKA"></a> |
</div> | </div> | ||
<div class="navbar-collapse collapse menu"> | <div class="navbar-collapse collapse menu"> | ||
<ul class="nav navbar-nav"> | <ul class="nav navbar-nav"> | ||
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil">HOME</a></li> |
- | <li | + | <li class="dropdown"> |
<a href="#" class="dropdown-toggle" data-toggle="dropdown">TEAM<span class="caret"></span></a> | <a href="#" class="dropdown-toggle" data-toggle="dropdown">TEAM<span class="caret"></span></a> | ||
<ul class="dropdown-menu" role="menu"> | <ul class="dropdown-menu" role="menu"> | ||
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Partnerships">Partnerships</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/TeamProfile">Official Team Profile</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Advisors">Advisors</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 47: | Line 277: | ||
<a href="#" class="dropdown-toggle" data-toggle="dropdown">PROJECT<span class="caret"></span></a> | <a href="#" class="dropdown-toggle" data-toggle="dropdown">PROJECT<span class="caret"></span></a> | ||
<ul class="dropdown-menu" role="menu"> | <ul class="dropdown-menu" role="menu"> | ||
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Overview">Overview</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Robot">Robot</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/ColiAlert">ColiAlert</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/BioSensor">Biosensor</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 56: | Line 286: | ||
<a href="#" class="dropdown-toggle" data-toggle="dropdown">PARTS<span class="caret"></span></a> | <a href="#" class="dropdown-toggle" data-toggle="dropdown">PARTS<span class="caret"></span></a> | ||
<ul class="dropdown-menu" role="menu"> | <ul class="dropdown-menu" role="menu"> | ||
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Biobricks">Biobricks</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Notebook">Notebook</a></li> |
</ul> | </ul> | ||
- | </li> | + | </li> |
- | + | <li class="dropdown"> | |
<a href="#" class="dropdown-toggle" data-toggle="dropdown">HUMAN PRACTICE<span class="caret"></span></a> | <a href="#" class="dropdown-toggle" data-toggle="dropdown">HUMAN PRACTICE<span class="caret"></span></a> | ||
<ul class="dropdown-menu" role="menu"> | <ul class="dropdown-menu" role="menu"> | ||
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Lectures">Lectures</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Society">Survey and Society Interaction</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/MeetUp ">Meet Up</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/SocialImpact">Social Impact</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Safety">SAFETY</a></li> |
- | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:LIKA-CESAR-Brasil/Atribuitons">ATRIBUITIONS</a></li> |
+ | <li class="igem-logo"><a href="https://2014.igem.org/"></a></li> | ||
</ul> | </ul> | ||
</div><!--/.nav-collapse --> | </div><!--/.nav-collapse --> | ||
Line 77: | Line 308: | ||
</div> | </div> | ||
<!-- Main jumbotron for a primary marketing message or call to action --> | <!-- Main jumbotron for a primary marketing message or call to action --> | ||
- | <div class="jumbotron"></div> | + | <div class="jumbotron" style="margin-top:80px;"></div> |
<div class="container"> | <div class="container"> | ||
<!-- Example row of columns --> | <!-- Example row of columns --> |
Latest revision as of 02:35, 18 October 2014
The partnerships
The partnerships: The junction of two so different institutes is no wonder. For the challenges that it proposes to solve, the team needs depth multidisciplinary allied to sync to aggregate together medical and laboratory challenges that are in the LIKA's field of study, with the already recognized C.E.S.A.R.'s technology expertise.
WHO IS LIKA: Laboratory of Immunopathology Keizo Asami (LIKA), is a laboratory of the Federal University of Pernambuco, founded in 1986 that has several lines of research. Among them, the diagnosis and the proposition of new therapeutic procedures. Works in the development of strategies to increase resolution for diagnosis of genetic diseases, infectious agents, and acquired autoimmune diseases. The LIKA's mission is to build quality human resources and develop methods, systems and biotechnological products associated with diagnostic and therapeutic methods human or animal, for better quality of life for all. Develop scientific and technological activities aimed at creation and transmission of knowledge.
WHO IS C.E.S.A.R.: Recife Center for Advanced Studies and Systems (C.E.S.A.R.) is a nonprofit institute that generates innovation when working with the solution of complex problems using information technology and robotics. With a multidisciplinary team, the CESAR offers differentiated positioning solutions to developing, operating in various industries. Synthetic biology is the newest area that the institute intends to operate in the coming years.